Published in J Biol Chem on December 10, 1984
2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an extensive alteration of 17 beta-estradiol metabolism in MCF-7 breast tumor cells. Proc Natl Acad Sci U S A (1990) 1.21
Phosphorylation, glycosylation, and proteolytic activity of the 52-kD estrogen-induced protein secreted by MCF7 cells. J Cell Biol (1987) 1.13
Oestrogen-induced pS2 protein is similar to pancreatic spasmolytic polypeptide and the kringle domain. Biochem J (1988) 0.87
Differential biological significance of tissue-type and urokinase-type plasminogen activator in human breast cancer. Br J Cancer (1993) 0.86
Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor. Br J Cancer (1998) 0.86
Long-term estrogen exposure promotes carcinogen bioactivation, induces persistent changes in gene expression, and enhances the tumorigenicity of MCF-7 human breast cancer cells. Toxicol Appl Pharmacol (2009) 0.83
Fibrinogen degradation product fragment D induces endothelial cell detachment by activation of cell-mediated fibrinolysis. J Clin Invest (1992) 0.82
Binding of urokinase to specific receptor sites on human breast cancer membranes. Br J Cancer (1987) 0.80
The influence of antiestrogens on the release of plasminogen activator (uPA) by MDA-MB-231 and MCF-7 breast cancer cells. Clin Exp Metastasis (1998) 0.75
Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol (2001) 7.46
Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases. Br J Dermatol (1968) 4.42
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1999) 4.15
ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol (1997) 3.14
Appropriateness of coronary angiography after myocardial infarction among Medicare beneficiaries. Managed care versus fee for service. N Engl J Med (2000) 2.75
The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med (1991) 2.74
Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent. JAMA (2000) 2.59
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol (1999) 2.58
Integrated management of filarial lymphedema for rural communities. Lymphology (2007) 2.54
Right ventricular infarction. N Engl J Med (1994) 2.48
Predictors of mortality for patients undergoing cardiac valve replacements in New York State. Ann Thorac Surg (2000) 2.39
The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol (1999) 2.37
ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol (1998) 2.27
Clinical and angiographic predictors of operative mortality from the collaborative study in coronary artery surgery (CASS). Circulation (1981) 2.27
The prognosis of generalized pustular psoriasis. Br J Dermatol (1971) 2.15
Coronary angioplasty volume-outcome relationships for hospitals and cardiologists. JAMA (1997) 2.11
Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. J Am Coll Cardiol (1984) 1.91
ACC/AHA guidelines for exercise testing: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). Circulation (1997) 1.83
Coronary arteriography and coronary artery bypass surgery: morbidity and mortality in patients ages 65 years or older. A report from the Coronary Artery Surgery Study. Circulation (1983) 1.83
Exercise stress testing. Correlations among history of angina, ST-segment response and prevalence of coronary-artery disease in the Coronary Artery Surgery Study (CASS). N Engl J Med (1979) 1.79
Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation (1982) 1.79
Methionyl soluble ribonucleic acid transformylase. I. Purification and partial characterization. J Biol Chem (1967) 1.74
Percutaneous laser thermal angioplasty: initial clinical results with a laser probe in total peripheral artery occlusions. Lancet (1986) 1.72
Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest (1983) 1.70
Prognostic significance of angiographically documented left ventricular aneurysm from the Coronary Artery Surgery Study (CASS). Am J Cardiol (1982) 1.65
Larva therapy in wound management. J R Soc Med (2000) 1.59
Prevention of coronary artery disease. A medical imperative. N Engl J Med (1990) 1.58
Vesiculo-bullous Darier's disease. Br J Dermatol (1990) 1.52
Inferior myocardial infarction. High-risk subgroups. Circulation (1990) 1.52
The relationship between operator volume and outcomes after percutaneous coronary interventions in high volume hospitals in 1994-1996: the northern New England experience. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol (1999) 1.50
Donor attitudes about exporting and importing blood. Transfusion (1997) 1.43
Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol (1992) 1.43
Diagnos and management of massive pulmonary embolism. Surg Clin North Am (1968) 1.42
Evidence-based humanitarian relief interventions. Lancet (1995) 1.41
THE USE OF THE RUSSELL APPARATUS IN THE TREATMENT OF FRACTURES OF THE SHAFT OF THE FEMUR. Ann Surg (1927) 1.38
Comparison of coronary artery bypass surgery and medical therapy in patients 65 years of age or older. A nonrandomized study from the Coronary Artery Surgery Study (CASS) registry. N Engl J Med (1985) 1.36
Chromosomal abnormalities produced by folic acid antagonists. Br J Dermatol (1965) 1.36
Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure. Circulation (1981) 1.35
Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol (1996) 1.31
Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation (1994) 1.31
Psychological correlates of coronary angiographic findings. Arch Intern Med (1976) 1.31
Angiotensin converting enzyme inhibition in patients with congestive heart failure. Circulation (1978) 1.30
Use of ESAT-6 in the interferon-gamma test for diagnosis of bovine tuberculosis following skin testing. Vet Microbiol (2001) 1.28
Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI II. J Am Coll Cardiol (1992) 1.26
Multivariate discriminant analysis of the clinical and angiographic predictors of operative mortality from the Collaborative Study in Coronary Artery Surgery (CASS). J Thorac Cardiovasc Surg (1980) 1.26
Medical versus early surgical therapy in patients with triple-vessel disease and mild angina pectoris: a CASS registry study of survival. Ann Thorac Surg (1987) 1.24
Lymphatics of the skin. Neglected but important. Int J Dermatol (1986) 1.24
Impact of underuse, overuse, and discretionary use on geographic variation in the use of coronary angiography after acute myocardial infarction. Med Care (2001) 1.23
Comparison of the clinical profile and outcome of women and men in cardiac rehabilitation. Am J Cardiol (1992) 1.22
2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an extensive alteration of 17 beta-estradiol metabolism in MCF-7 breast tumor cells. Proc Natl Acad Sci U S A (1990) 1.21
Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy. Am Heart J (1981) 1.19
International comparisons of waiting times for cardiovascular procedures: a commentary on the long queue. J Am Coll Cardiol (1995) 1.18
A model of bovine tuberculosis control in domesticated cattle herds. Proc Biol Sci (1997) 1.18
Delayed pressure urticaria. Br J Dermatol (1968) 1.16
Use of mycobacterial peptides and recombinant proteins for the diagnosis of bovine tuberculosis in skin test-positive cattle. Vet Rec (2003) 1.15
Herniation of mitral leaflets in the Ehlers-Danlos syndrome. Am J Cardiol (1975) 1.14
Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure. J Am Coll Cardiol (1985) 1.14
Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure. Mol Psychiatry (2012) 1.14
Effect of phenylhydrazine-induced hemolytic anemia on nuclear RNA polymerase activity of the mouse spleen. Blood (1973) 1.14
The structure and mechanism of action of bacterial DNA-dependent RNA polymerase. Prog Biophys Mol Biol (1981) 1.13
Reversal of diabetic nephropathy in human cadaveric kidneys after transplantation into non-diabetic recipients. Lancet (1983) 1.13
A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. J Am Coll Cardiol (1999) 1.12
Glutamyl hydrolase. pharmacological role and enzymatic characterization. Pharmacol Ther (2000) 1.11
Report of the Joint ISFC/WHO Task Force on Coronary Angioplasty. The International Society and Federation of Cardiology and the World Health Organization. Circulation (1988) 1.10
Prognostic assessment of patients with coronary artery disease by exercise testing. Am Heart J (1983) 1.10
Cutaneous angiitis. Patterns of rashes explained by (1) flow properties of blood; (2) anatomical disposition of vessels. Br J Dermatol (1971) 1.10
A potent mercapto bi-product analogue inhibitor for human carboxypeptidase N. Biochem Biophys Res Commun (1981) 1.10
Vasculitis--immunology and localization: a review. J R Soc Med (1979) 1.09
Nucleotidases in plants. I. Partial purification and properties of the enzyme hydrolyzing flavine adenine dinucleotide from mung bean seedlings (Phaseolus radiatus). Arch Biochem Biophys (1965) 1.09
Studies on the product binding sites of the Azotobacter vinelandii ribonucleic acid polymerase. J Biol Chem (1975) 1.08
Human papillomavirus type 6-induced condylomata: an unusual complication of intertrigo. Br J Dermatol (1993) 1.08
The direction of growth of epithelium. Br J Dermatol (1966) 1.07
What are subcutaneous adipocytes really good for? Exp Dermatol (2007) 1.06
Right coronary artery stenosis: an independent predictor of atrial fibrillation after coronary artery bypass surgery. J Am Coll Cardiol (1995) 1.06
Experience with latrogenic pediatric vascular injuries. Incidence, etiology, management, and results. Ann Surg (1983) 1.06
Experimental angioplasty: circumferential distribution of laser thermal energy with a laser probe. J Am Coll Cardiol (1985) 1.06
Fibrinolytic activity of skin suface lipids. Lancet (1971) 1.06
Determinants of successful percutaneous transluminal coronary angioplasty: report from the National Heart, Lung, and Blood Institute Registry. Am Heart J (1984) 1.06
Congenital erythropoietic porphyria. Report of a case. Br J Dermatol (1967) 1.05
Ligand-induced change in the radius of gyration of cAMP receptor protein from Escherichia coli. FEBS Lett (1980) 1.05
ST segment changes post-infarction: predictive value for multivessel coronary disease and left ventricular aneurysm. Circulation (1978) 1.05
The critical question of procedure volume minimums for coronary angioplasty. JAMA (1995) 1.04
Localization and differential regulation of angiotensinogen mRNA expression in the vessel wall. J Clin Invest (1991) 1.04
Microvascular pattern and blood stasis in skin disease. Br J Dermatol (1969) 1.03
Acute effects of transluminal angioplasty in three experimental models of atherosclerosis. Arteriosclerosis (1982) 1.02
Intra-aortic balloon assist for postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg (1973) 1.01
Fibrinolytic activity in human skin. Trans St Johns Hosp Dermatol Soc (1969) 1.01
Early revascularization in cardiogenic shock--a positive view of a negative trial. N Engl J Med (1999) 1.01
The effectiveness of acne treatment: an assessment by patients of the outcome of therapy. Br J Dermatol (1997) 1.00